(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Diabetes is the most prevalent metabolic disorder in the world. With many types of therapies available, including the mainstay insulin, the disease is manageable in most people. However, current anti-diabetes medications act primarily on peripheral end organs to regulate glucose and insulin levels. Dopamine agonist therapy, which targets the neuroendocrine patterns associated with insulin resistance, is a novel approach for diabetes treatment. Part of the Oxford American Pocket Cards series, this portable, ultra-concise and up-to-date brochure provides key clinical insight as well as dosing and administration guidelines for newly FDA-approved dopamine agonist therapy for Type 2 diabetes. To purchase this product, please contact U.S. Medical Sales at MedSales@oup.com
PRODUCT DETAILS
Publisher: Oxford University Press (Oxford University Press Inc)
Publication date: July, 2010
Pages: None
Weight: 10g
Availability: Contact supplier
Subcategories: Endocrinology